See more : Prime Energy P.E. Ltd (PRIM.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Dayang Biology Technology Co.,Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- Shelf Drilling, Ltd. (SHLLF) Income Statement Analysis – Financial Results
- Banco de Chile (BCH) Income Statement Analysis – Financial Results
- Star Jets International, Inc. (JETR) Income Statement Analysis – Financial Results
- Highbank Resources Ltd. (HBKRF) Income Statement Analysis – Financial Results
- Beverly Hills Bancorp Inc. (BHBCQ) Income Statement Analysis – Financial Results
Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ)
About Zhejiang Dayang Biology Technology Co.,Ltd.
Zhejiang Dayang Biology Technology Co.,Ltd. engages in research and development, production, and sale of biological products, agricultural chemicals, and chemical in China and internationally. The company's products include food additive potassium carbonate, potassium carbonate, food additive potassium bicarbonate, potassium bicarbonate, agricultural grade ammonium chloride, and industrial grade ammonium chloride. It also offers chemical products, such as 2-chloro-6-fiuorobenzaldehyde, 2-chloro-6-fluorobenzyl chloride, and anisole products; veterinary APIs, including amprolium HCL; and veterinary drug premixes comprising enramycin premixes. The company was founded in 1976 and is based in Jiande, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 919.45M | 1.06B | 783.21M | 678.34M | 621.75M | 584.16M | 554.72M | 441.23M | 448.10M | 458.57M | 499.72M |
| Cost of Revenue | 753.18M | 911.85M | 631.05M | 512.65M | 465.49M | 433.76M | 416.09M | 335.92M | 350.16M | 364.72M | 392.36M |
| Gross Profit | 166.28M | 146.25M | 152.16M | 165.69M | 156.26M | 150.40M | 138.63M | 105.31M | 97.94M | 93.84M | 107.37M |
| Gross Profit Ratio | 18.08% | 13.82% | 19.43% | 24.43% | 25.13% | 25.75% | 24.99% | 23.87% | 21.86% | 20.46% | 21.49% |
| Research & Development | 39.22M | 34.06M | 27.84M | 22.33M | 20.48M | 18.23M | 39.26M | 35.40M | 0.00 | 18.69M | 14.78M |
| General & Administrative | 65.28M | 13.54M | 16.21M | 15.16M | 11.49M | 13.89M | -33.11M | -900.19K | 58.64M | 49.83M | 47.74M |
| Selling & Marketing | 9.82M | 8.83M | 7.47M | 7.28M | 21.67M | 20.93M | 20.33M | 17.40M | 13.13M | 17.67M | 17.49M |
| SG&A | 73.53M | 22.38M | 23.68M | 22.44M | 33.16M | 34.82M | -12.78M | 16.50M | 71.78M | 71.95M | 67.96M |
| Other Expenses | -666.18K | 33.14M | 27.29M | 16.74M | 14.34M | -3.60M | 4.57M | 14.14M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 109.98M | 89.57M | 78.82M | 61.51M | 67.98M | 67.93M | 69.35M | 79.33M | 73.67M | 57.42M | 71.14M |
| Cost & Expenses | 863.16M | 1.00B | 709.86M | 574.16M | 533.47M | 501.70M | 485.44M | 415.25M | 423.83M | 422.14M | 463.49M |
| Interest Income | 7.67M | 1.29M | 575.82K | 674.09K | 89.80K | 87.26K | 261.94K | 234.99K | 0.00 | 7.78M | 8.95M |
| Interest Expense | 6.68M | 5.48M | 3.72M | 665.75K | 1.63M | 2.98M | 8.84M | 7.85M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 69.67M | 60.25M | 45.01M | 30.99M | 30.08M | 25.89M | 24.51M | 22.81M | 21.48M | 20.13M | 19.80M |
| EBITDA | 122.80M | 120.87M | 125.39M | 132.84M | 118.90M | 104.87M | 84.16M | 61.71M | 45.30M | 37.81M | 53.66M |
| EBITDA Ratio | 13.36% | 11.42% | 16.14% | 19.47% | 18.95% | 17.95% | 16.62% | 14.46% | 10.11% | 8.25% | 10.74% |
| Operating Income | 56.29M | 59.19M | 79.33M | 101.71M | 87.10M | 78.75M | 57.56M | 17.37M | 23.82M | 17.68M | 33.86M |
| Operating Income Ratio | 6.12% | 5.59% | 10.13% | 14.99% | 14.01% | 13.48% | 10.38% | 3.94% | 5.32% | 3.86% | 6.78% |
| Total Other Income/Expenses | -9.31M | -1.74M | -3.19M | -1.45M | -376.17K | -3.60M | -2.18M | 13.74M | 446.56K | 21.25M | 4.68M |
| Income Before Tax | 46.99M | 57.45M | 76.14M | 100.26M | 86.73M | 75.15M | 55.37M | 31.04M | 24.27M | 28.64M | 27.28M |
| Income Before Tax Ratio | 5.11% | 5.43% | 9.72% | 14.78% | 13.95% | 12.86% | 9.98% | 7.04% | 5.42% | 6.25% | 5.46% |
| Income Tax Expense | -3.02M | -23.27M | 6.13M | 8.65M | 7.23M | 4.35M | 5.12M | 2.19M | 605.36K | 566.11K | 990.03K |
| Net Income | 50.01M | 80.73M | 70.01M | 91.61M | 79.50M | 70.80M | 50.26M | 28.82M | 23.67M | 28.07M | 26.32M |
| Net Income Ratio | 5.44% | 7.63% | 8.94% | 13.50% | 12.79% | 12.12% | 9.06% | 6.53% | 5.28% | 6.12% | 5.27% |
| EPS | 0.62 | 0.99 | 0.83 | 1.09 | 0.95 | 1.69 | 1.30 | 0.86 | 0.72 | 0.61 | 0.57 |
| EPS Diluted | 0.62 | 0.99 | 0.83 | 1.09 | 0.95 | 1.69 | 1.30 | 0.86 | 0.72 | 0.61 | 0.57 |
| Weighted Avg Shares Out | 80.73M | 81.47M | 84.00M | 84.00M | 84.00M | 41.89M | 38.66M | 33.51M | 32.87M | 46.24M | 46.07M |
| Weighted Avg Shares Out (Dil) | 80.73M | 81.54M | 84.00M | 84.00M | 84.00M | 41.89M | 38.66M | 33.51M | 32.87M | 46.24M | 46.07M |
Source: https://incomestatements.info
Category: Stock Reports